IGF-1: The Hidden Hormone That Fuels Cancer (And How to Lower It Naturally)

You may not have heard of insulin-like growth factor 1 (IGF-1)—but this powerful hormone could be quietly influencing your risk of cancer, aging, and chronic disease. IGF-1 plays a role in healthy childhood development as well as healthy aging, but too much of it may do more harm than good.
Here’s what the science shows—and how a Nutritarian diet may be your most powerful defense.
The Problem: When Growth Turns Dangerous
IGF-1 helps your cells grow and divide. That’s great when you’re a child—but in adults, it’s more complicated. Lower (but not excessively low) IGF-1 activity is linked to longevity, but excessively high IGF-1 can fuel abnormal cell growth, suppress apoptosis (the natural death of damaged cells), and drive the development of cancer. Also, at older ages (over 65 or 70), IGF-1 production slows and levels that are too low become a bigger concern, since IGF-1 is necessary to maintain bone and muscle mass as well as cognitive function.1-8
Higher IGF-1 levels have been linked to:
• Increased risk of breast, prostate, and colorectal cancers9-11
• Accelerated aging and premature death12
• Greater resistance to cancer therapies13
• A higher likelihood of developing a second cancer in cancer survivors14
IGF-1 isn’t inherently bad—but it must be balanced. Unfortunately, the standard American diet drives IGF-1 levels dangerously high, especially due to excess animal protein and refined carbohydrates.
Sources:
Protein Requirements and Optimal Intakes in Aging: Are We Ready to Recommend More Than the Recommended Daily Allowance?
Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population
Nutrition, GH/IGF-1 signaling, and cancer
GH and IGF1 in cancer therapy resistance
Is there a role for IGF-1 in the development of second primary cancers?
The Evidence: What the Research Says is the Optimal IGF-1 Level
A meta-analysis of 19 studies including over 30,000 participants found that IGF-1 levels that are too high or too low are associated with a greater risk of early death. The sweet spot? Between 120 and 160 ng/ml.12
Source:
Association between IGF-1 levels ranges and all-cause mortality: A meta-analysis
The Solution: Eat for a healthy IGF-1 Level
IGF-1 levels peak in our teens and twenties and decline with age. Apart from age, dietary protein intake is the major regulator of IGF-1 levels, especially animal protein. Since essential amino acids in particular trigger the production of IGF-1, animal protein, which is higher in essential amino acids than plant protein, increases IGF-1 more than plant protein.15-17 High-glycemic, refined carbohydrates also raise IGF-1 somewhat.18-20 Western diets rich in meat, dairy, and refined carbohydrate commonly push IGF-1 levels over 200 ng/ml (in young and middle-aged adults), raising the risk for cancers.4
To extend your lifespan and reduce cancer risk, aim for an IGF-1 level that's low, but not too low—especially after age 75, when IGF-1 is essential for maintaining bone, brain, and muscle health.
Here’s how to do it:
- Ditch animal protein for plant protein. Replace meat, eggs, and dairy with beans, lentils, tofu, nuts, and seeds. The amino acid profile of animal protein triggers excessive IGF-1 production.
- Adopt a Nutritarian diet. This eating style emphasizes plant food diversity and ensures you get adequate protein from greens, seeds, and legumes—without over-activating IGF-1.
Related: How Plant Protein Wins Over Animal Protein
Sources:
Nutritional regulation of the insulin-like growth factors
Association of animal and plant protein intakes with biomarkers of insulin and insulin-like growth factor axis
The insulin-like growth factor axis: a potential link between glycemic index and cancer
Why a Nutritarian Diet Keeps IGF-1 Levels Favorable
Restricting animal protein during most of adult life to maintain a relatively low, but not excessively low IGF-1 is an important objective for those desirous of superior health and life extension. Unlike other plant-based diets that may fall short on protein in later life, the Nutritarian approach is designed to sustain optimal IGF-1 levels throughout life with plant protein-rich foods such as greens, beans (including soybeans), and seeds. By emphasizing phytochemical-rich foods and plant protein, it helps:
- Prevent cancer by keeping IGF-1 in the safe range
- Support longevity by protecting against frailty in older adults
- Ensure micronutrient completeness and phytochemical variety to reduce inflammation, improve immunity, and reverse disease
Dr. Fuhrman’s medical practice and decades of research show that this is not just a theory—it’s a proven path to a longer, healthier life.
Take Action
Here’s your IGF-1 challenge:
This week, swap out meat or dairy in at least 3 meals. Use beans instead of beef. Blend your smoothie with flax seeds, hemp seeds, and kale instead of whey protein. Try a cashew cheese recipe in place of cheddar.
If you’ve never had your IGF-1 levels tested, ask your doctor to include it in your next routine blood panel or use an at-home test, especially if you're over age 70. And if you’re working on cancer prevention or recovery, keeping IGF-1 in check is one of the smartest moves you can make.
Related: What blood tests do I need?
Follow Dr. Fuhrman’s Proven Plan
Want more support? Join Dr. Fuhrman’s Nutritarian Membership and gain access to:
🌱 Over 2,000+ recipes using plant-based, cancer-fighting ingredients
📅 Step-by-step meal plans that simplify your health journey
📚 Science-backed guidance from Dr. Fuhrman and his team
👩🍳 Tools to help you ditch animal products and transform your plate—without sacrificing flavor
👉 Join the membership today and start optimizing your IGF-1 the delicious way.
- Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997, 278:419-424.
- Witard OC, McGlory C, Hamilton DL, Phillips SM. Growing older with health and vitality: a nexus of physical activity, exercise and nutrition. Biogerontology 2016, 17:529-546.
- Traylor DA, Gorissen SHM, Phillips SM. Perspective: Protein Requirements and Optimal Intakes in Aging: Are We Ready to Recommend More Than the Recommended Daily Allowance? Adv Nutr 2018, 9:171-182.
- Levine ME, Suarez JA, Brandhorst S, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab 2014, 19:407-417.
- Doi T, Shimada H, Makizako H, et al. Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed. Neurobiol Aging 2015, 36:942-947.
- Werner H, LeRoith D. Hallmarks of cancer: The insulin-like growth factors perspective. Front Oncol 2022, 12:1055589.
- Balasubramanian P, Longo VD. Growth factors, aging and age-related diseases. Growth Horm IGF Res 2016, 28:66-68.
- Fanti M, Longo VD. Nutrition, GH/IGF-1 signaling, and cancer. Endocr Relat Cancer 2024, 31.
- Watts EL, Perez-Cornago A, Fensom GK, et al. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. International Journal of Epidemiology 2022, 52:71-86.
- Murphy N, Knuppel A, Papadimitriou N, et al. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with approximately 430 000 women. Ann Oncol 2020, 31:641-649.
- Murphy N, Carreras-Torres R, Song M, et al. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Gastroenterology 2020, 158:1300-1312.e1320.
- Rahmani J, Montesanto A, Giovannucci E, et al. Association between IGF-1 levels ranges and all-cause mortality: A meta-analysis. Aging Cell 2022, 21:e13540.
- Basu R, Kopchick JJ. GH and IGF1 in cancer therapy resistance. Endocrine-Related Cancer 2023, 30:e220414.
- Shanmugalingam T, Bosco C, Ridley AJ, Van Hemelrijck M. Is there a role for IGF-1 in the development of second primary cancers? Cancer Med 2016, 5:3353-3367.
- Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994, 15:80-101.
- Clemmons DR, Seek MM, Underwood LE. Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor I response to refeeding after fasting. Metabolism 1985, 34:391-395.
- Lee DH, Tabung FK, Giovannucci EL. Association of animal and plant protein intakes with biomarkers of insulin and insulin-like growth factor axis. Clin Nutr 2022, 41:1272-1280.
- Runchey SS, Pollak MN, Valsta LM, et al. Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study. Eur J Clin Nutr 2012, 66:1146-1152.
- Brand-Miller JC, Liu V, Petocz P, Baxter RC. The glycemic index of foods influences postprandial insulin-like growth factor-binding protein responses in lean young subjects. American Journal of Clinical Nutrition 2005, 82:350-354.
- Biddinger SB, Ludwig DS. The insulin-like growth factor axis: a potential link between glycemic index and cancer. Am J Clin Nutr 2005, 82:277-278.
Related

